Turner ML, Jovic TH, Bullock LS, Hill L, Thomas BR, Gazze SA, Maffeis TGG, Francis LW, Hawkins K, Sillmann YM, Baggio AMP, Dunstan PR, Thornton CA, Guastaldi FPS, Randolph MA, Whitaker IS (2026). Characterization, biocompatibility, and immunogenicity of tunicate-derived nanocellulose for tissue engineering. Carbohydrate Polymers, 375: 124671. https://doi.org/10.1016/j.carbpol.2025.124671
We work towards a longer and healthier life for the human population. The business of Ocean TuniCell is to provide clinically relevant hydrogel biomaterial that can bridge the gap between the research community and clinicians in order to facilitate the translational process in the field of regenerative medicine. Our core invention is the production and processing of medical grade tunicate nanofibrillar cellulose, TUNICELL, with excellent properties for 3D reconstruction of tissues and organs. We aim to be the preferred biomaterial supplier for in vitro and in vivo applications within the field.












